Sovereign AI governance of UK Industrial Injuries Disablement Benefit — disease prescription, assessment panels, reduced earnings allowance, and disablement pension calculation. 12 entry points × 8 transformation priorities × 6 MCPs. Audit-grade. Signed. UK-sovereign.
Employed earner's employment verification against NI records. Prescribed disease or industrial accident causation test. 90-day waiting period from onset of incapacity. NI Class 1 contribution test in relevant tax year. Self-employed exclusion and cross-scheme routing. Prescribed occupation or process validation. Latent disease onset date determination. Causal link evidence threshold. Multiple employment aggregation. Part-time and casual worker qualification under SS(C)A 1992.
Medical board percentage disablement assessment (1-100%). ADP assessment panel protocol. Accepted medical condition benchmarks. Unemployability supplement eligibility (100% + incapacity). Constant Attendance Allowance trigger at 100%. Review and reassessment scheduling. Overlapping benefit assessment with other pensions. Hospital inpatient adjustment. Prognosis modelling for latent disease progression. Appeal tribunal evidence preparation.
PD A1-PD list governance and maintenance. Occupational deafness (PD A10). Vibration white finger (PD A12). Pneumoconiosis (PD D1-D7). Mesothelioma (PD D3/D8) asbestos-related cancer fast-track. Occupational asthma (PD D7). Occupational dermatitis (PD D5/D6). Tenosynovitis (PD A4). Occupational cancer (PD C1-C20). Prescription list updates requiring Parliamentary review.
REA calculation based on loss of earning capacity. Pre/post-disablement earnings comparison. Weekly earnings reduction assessment. ROP automatic conversion at state pension age. REA rate bands (100/75/50/25%). Overlapping benefit interaction with UC, ESA, IB. Permitted work rules and earnings disregard. Supersession on change of circumstances. ROP uprating aligned with CPI.
CAA eligibility at 100% disablement assessment. Daily attendance needs verification by medical board. CAA rate tiers — normal, intermediate, exceptional. GP, consultant, and carer attendance evidence. CAA and Attendance Allowance overlap rules. Hospital inpatient suspension after 28 days. Review scheduling for fluctuating conditions. CAA arrears from qualifying disablement date. Carer's Allowance cross-referral. PIP daily living component interaction.
Medical board challenge and reconsideration request. First-tier Tribunal (Social Entitlement Chamber) appeal. New medical evidence and expert witness protocol. Appeal time limits (1 month from decision). Late appeal good cause assessment. Supersession on change of medical condition. Review for increased disablement percentage. Pre-hearing case conference and disclosure. Appeal outcome analytics and precedent tracking.
NI industrial injuries scheme contribution verification. HMRC PAYE record cross-match. Employer liability determination for disease claims. Contribution record completeness check (Class 1 NIC). Employer notification of injury/disease claim. Contribution credit for sickness periods. Employer defence against liability claims. Historical employer tracing for latent diseases. Group employer contribution aggregation. Contribution audit and compliance reporting.
Universal Credit taper during IIDB receipt. ESA new-style eligibility cross-check on IIDB exhaustion. PIP daily living and CAA overlap analysis. Attendance Allowance and CAA overlapping rules. Incapacity Benefit to IIDB transition pathway. Bereavement benefits on IIDB claimant death. Pension Credit income assessment. Housing Benefit preservation during IIDB. Benefits cap interaction analysis. Carer's Allowance and CAA cross-referral.
Mesothelioma fast-track (PD D3/D8) — 28-day target. DMPS cross-referral. Asbestos lung cancer (PD D1) causation. Pleural thickening (PD D4) and asbestosis (PD D1) staged assessment. Pneumoconiosis Medical Panel evidence. Latent disease onset determination (decades-long latency). Historical employer tracing via HMRC/HSE data. 1979 Workers' Compensation Act claim routing. Mesothelioma UK nurse specialist cross-referral. Asbestos trend monitoring for HSE action.
PD A10 occupational deafness processing. Audiometric threshold evidence (pure tone audiogram). Tinnitus assessment and combined disability weighting. Noise exposure history from employer records. Prescribed occupation list verification. Noise level evidence from HSE data. NHS audiology cross-referral. Employer liability notification. Deafness trend monitoring by sector. Audiometric testing quality assurance.
Caseload monitoring (~300K claims/yr). Disease trend analysis by PD category. Occupational health surveillance integration. Regional and sector disease incidence mapping. Mesothelioma mortality trend forecasting. Occupational deafness prevalence by industry. Asbestos exposure risk mapping from HSE data. Claimant demographic profiling. IIDB/UC/ESA/PIP interaction analytics. Parliamentary statistics publication pipeline.
IIDB statistics publication for Parliamentary debates. Industrial disease policy reform evidence. Prescription list update governance and consultation. Prescribed disease addition/removal impact assessment. Asbestos policy reform from caseload data. Occupational deafness threshold analysis. REA/ROP reform and fiscal impact modelling. Cross-party briefing packs on disease trends. International comparison with EU schemes. Ministerial submission preparation.
End-to-end digital medical board and ADP assessment workflow. Remote assessment for mobility-restricted claimants. Standardised digital criteria against PD benchmarks. Automated percentage disablement calculation. Panel decision audit trail with full evidence chain. Target 90% digital-first assessments by 2028. Eliminate paper medical board processing.
AI-assisted disease classification against PD A1-PD list. Automated causal link assessment from employment and medical records. Symptom-to-disease mapping for GP referrals. Latent disease onset date prediction. Disease progression modelling for reassessment. Target 95% accurate classification without specialist panel delay. Reduce classification time from 12 weeks to 4 weeks.
28-day processing guarantee for all mesothelioma claims. Automated DMPS cross-referral on diagnosis. Historical employer tracing via HMRC/HSE data. Pneumoconiosis Panel digital evidence. Latent disease onset AI calculation. Target zero delay in asbestos claims. Eliminate manual employer tracing bottleneck.
Real-time NI verification via HMRC RTI. Automated employer notification on claim submission. Contribution record completeness pre-check. Historical employer tracing for latent diseases. Liability workflow with HMRC evidence chain. Target 48-hour verification for 90% of claims. Eliminate contribution record gaps blocking entitlement.
Single record across IIDB/UC/ESA/PIP/AA/IB. Automated eligibility cascade from IIDB assessment. REA/ROP conversion at pension age without claimant action. CAA-to-PIP cross-referral. No claimant navigating five benefit systems. Target zero income gap during transition. Privacy-by-design digital identity.
IIDB disease trend integration with HSE enforcement. Real-time occupational disease alerting by sector. Asbestos exposure risk mapping from IIDB data. Noise-induced deafness trend monitoring. Occupational asthma/dermatitis sector alerts. Target predictive surveillance across UK industries. Feed IIDB intelligence into HSE inspection targeting.
Digital appeals workflow from reconsideration to tribunal. Automated evidence collection and disclosure. Appeal time limit tracking with good cause assessment. Pre-hearing digital case conference. Appeal outcome analytics and precedent database. Target 60-day resolution (from 120+ days). Reduce adjournment rate by 50%.
Predictive modelling for emerging occupational disease trends. Cross-referencing IIDB claims with HSE exposure data. Asbestos mortality forecasting from incidence curves. Occupational deafness prediction by sector growth. Chemical exposure risk from new processes. Target proactive prescription list updates. Feed intelligence into Parliamentary reform evidence.
Employed earner verification. NI Class 1 contribution test. 90-day waiting period. Prescribed disease causation. Self-employed exclusion routing. Multiple employment aggregation. Latent disease onset determination. Part-time qualification. SS(C)A 1992 compliance.
Medical board protocol. ADP percentage disablement. Unemployability supplement. CAA trigger at 100%. Review scheduling. Hospital inpatient adjustment. Prognosis modelling. Appeal evidence preparation.
PD A1-PD list governance. Occupational deafness (PD A10). Vibration white finger (PD A12). Pneumoconiosis (PD D1-D7). Mesothelioma (PD D3/D8). Asthma (PD D7). Dermatitis (PD D5/D6). Tenosynovitis (PD A4). Cancer (PD C1-C20). Prescription updates.
REA earning capacity calculation. Pre/post-disablement comparison. ROP conversion at pension age. Rate bands (100/75/50/25%). Permitted work rules. Overlapping benefit interaction. Supersession. CPI uprating alignment.
Mesothelioma fast-track (28-day). DMPS cross-referral. Asbestos lung cancer. Pleural thickening assessment. Medical Panel evidence. Latent onset calculation. Historical employer tracing. 1979 Act routing. HSE data feed.
Caseload dashboard (~300K/yr). Disease trend analytics. OH surveillance. Regional incidence mapping. Mesothelioma forecasting. Parliamentary pipeline. International benchmarking. Prescription impact assessment. Reform simulation.